title: Methotrexate is the leading DMARD in Finland.
authors.forename: T
authors.initials: T
authors.lastname: Klaukka
authors.forename: K
authors.initials: K
authors.lastname: Kaarela
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D005387:Finland / Q000453:epidemiology; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D007348:Insurance, Health; D008727:Methotrexate / Q000627:therapeutic use*; D012216:Rheumatic Diseases / Q000188:drug therapy* / Q000453:epidemiology; D012460:Sulfasalazine / Q000627:therapeutic use
chemical_list: D018501:Antirheumatic Agents; D012460:Sulfasalazine; D006886:Hydroxychloroquine; D008727:Methotrexate